PRIMER: Promoting Research In MEdical Residency

入门读物:促进住院医师研究

基本信息

  • 批准号:
    10647842
  • 负责人:
  • 金额:
    $ 33.62万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2020
  • 资助国家:
    美国
  • 起止时间:
    2020-07-01 至 2024-06-30
  • 项目状态:
    已结题

项目摘要

Abstract Most residents view research during training favorably, yet few engage actively in research due to several barriers that render a physician scientist career unappealing. The Boston University-Boston Medical Center (BU-BMC) Multi-Disciplinary Program for Promoting Research In MEdical Residency (PRIMER) targets barriers, leverages BU's renowned institutional strengths in heart, lung, blood and sleep (HLBS) research, and expands our research training for internal medicine residents substantially. Our central objective is to provide a comprehensive ~2-year (contiguous 22 months of 80% protected research time, i.e., 17.6 months of 100% protected research time) training for medicine residents to pursue research in HLBS diseases, while ensuring their clinical board eligibility, and transition to a K38 award and a clinical fellowship. Our programmatic goals are to: (1) train 2 medicine residents every year over a 4-year period in one of four cutting-edge HLBS research tracks, i.e., clinical epidemiology and translational research; genomics, computational biology and bioinformatics; health systems research and implementation science; regenerative medicine, catering to both those with limited or advanced prior research training; (1a) train at least 2 underrepresented group (URG) and 3 women residents over the four-year period; (2) transition trainees to a K38 award as part of a post-R38 clinical fellowship. To achieve these goals, we offer the following specific aims (outcomes/milestones are underlined): (1) Provide broad transdisciplinary competency-based training in approaches to HLBS research to a PGY3 and a PGY4 resident every year, catering to both those with limited and. substantial previous research experience. We will enable attainment of core competencies including communication skills, grant writing, responsible conduct of research, study design, analysis and interpretation, and leadership and team science. (2) Feature personalized and mentored research projects for each trainee under the direction of an established NIH- or NSF-funded investigator in one of the four HLBS training tracks resulting in excellent scholarship. (3) Provide authentic career mentorship using an individualized development plan and ongoing assessment to facilitate transition to board eligibility in internal medicine, a K38 award, and a clinical HLBS fellowship. (4) Afford strong developmental support to recruit and retain trainees, especially URG and women residents. (5) Evaluate PRIMER processes and monitor outcomes continuously with summative and formative activities. PRIMER integrates program directors with complementary skills, a group mentoring approach with `trained' research and career mentors, opportunities for training and scholarship in four HLBS training pathways, an outstanding institutional environment that supports research, career and professional development of trainees, a rigorous competency-based learner-centered curriculum, and ambitious URG and women recruitment goals.
摘要 大多数住院医师在培训期间积极看待研究,但由于一些原因,很少有人积极参与研究。 使医生科学家职业失去吸引力的障碍。波士顿大学-波士顿医学中心 (BU-BMC)促进医学住院医师研究的多学科计划(PRIMER)目标 利用BU在心脏,肺,血液和睡眠(HLBS)研究方面的知名机构优势, 大幅扩展我们对内科住院医师的研究培训。我们的主要目标是提供一个 综合~2年(连续22个月的80%受保护研究时间,即,17.6 100%的月份 受保护的研究时间)培训医学住院医师进行HLBS疾病的研究,同时确保 他们的临床委员会资格,并过渡到K38奖和临床奖学金。 我们的计划目标是:(1)在四年的时间里,每年培训2名住院医师, 尖端的HLBS研究轨道,即,临床流行病学和转化研究;基因组学, 计算生物学和生物信息学;卫生系统研究和实施科学;再生 医学,迎合那些有限或先进的先前研究培训;(1a)培训至少2 在四年期间,为代表性不足的群体(URG)和3名女居民提供了培训;(2)将受训人员过渡到 K38奖作为后R38临床奖学金的一部分。 为了实现这些目标,我们提出了以下具体目标(结果/里程碑加下划线): (1)提供广泛的跨学科能力为基础的培训方法,以HLBS的研究,以PGY 3和 一个PGY 4居民每年,迎合那些有限的和。丰富的前期研究经验。 我们将使核心能力的实现,包括沟通技巧,赠款写作,负责任 开展研究,研究设计,分析和解释,以及领导和团队科学。 (2)在既定的指导下,为每位学员提供个性化和指导性的研究项目。 NIH或NSF资助的调查员在四个HLBS培训轨道之一,导致优秀的奖学金。 (3)通过个性化的发展计划和持续的评估提供真正的职业指导, 促进过渡到董事会资格在内科,K38奖,和临床HLBS奖学金。 (4)提供强有力的发展支持,以招募和留住受训人员,特别是URG和女性居民。 (5)通过总结性和形成性活动,评估PRIMER流程并持续监控结果。 PRIMER将项目主管与互补技能相结合,这是一种小组指导方法, 研究和职业导师,在四个HLBS培训途径的培训和奖学金的机会, 良好的体制环境,支持受训人员的研究、职业和专业发展, 严格的以能力为基础的以学习者为中心的课程,以及雄心勃勃的URG和妇女招聘目标。

项目成果

期刊论文数量(25)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Severe hyponatremia due to surreptitious water intoxication in a hospitalized patient.
  • DOI:
    10.1007/s13730-022-00733-y
  • 发表时间:
    2023-05
  • 期刊:
  • 影响因子:
    1
  • 作者:
    Claudel, Sophie E;Waikar, Sushrut S;Verma, Ashish
  • 通讯作者:
    Verma, Ashish
Lifetime Risk of Heart Failure and Trends in Incidence Rates Among Individuals With Type 2 Diabetes Between 1995 and 2018.
  • DOI:
    10.1161/jaha.121.021230
  • 发表时间:
    2021-11-02
  • 期刊:
  • 影响因子:
    5.4
  • 作者:
    Schwartz B;Pierce C;Vasan RS;Schou M;Ibrahim M;Monahan K;Lyass A;Malmborg M;Gislason GH;Køber L;Torp-Pedersen C;Andersson C
  • 通讯作者:
    Andersson C
Outcomes Associated With Surgical and Pharmacologic Treatment of Obesity in Heart Failure.
与心力衰竭肥胖症的手术和药物治疗相关的结果。
  • DOI:
    10.1161/circheartfailure.123.011323
  • 发表时间:
    2024
  • 期刊:
  • 影响因子:
    0
  • 作者:
    Claudel,SophieE;Powell-Wiley,TiffanyM
  • 通讯作者:
    Powell-Wiley,TiffanyM
Long-Term Mortality Associated With Use of Carvedilol Versus Metoprolol in Heart Failure Patients With and Without Type 2 Diabetes: A Danish Nationwide Cohort Study.
  • DOI:
    10.1161/jaha.121.021310
  • 发表时间:
    2021-09-21
  • 期刊:
  • 影响因子:
    5.4
  • 作者:
    Schwartz B;Pierce C;Madelaire C;Schou M;Kristensen SL;Gislason GH;Køber L;Torp-Pedersen C;Andersson C
  • 通讯作者:
    Andersson C
Prevalence and incidence of various cancer subtypes in patients with heart failure vs matched controls.
心力衰竭患者与匹配对照患者中各种癌症亚型的患病率和发病率。
  • DOI:
    10.1016/j.ijcard.2020.10.072
  • 发表时间:
    2021-03-01
  • 期刊:
  • 影响因子:
    3.5
  • 作者:
    Schwartz B;Schou M;Gislason GH;Køber L;Torp-Pedersen C;Andersson C
  • 通讯作者:
    Andersson C
{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Vanessa Xanthakis其他文献

Vanessa Xanthakis的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Vanessa Xanthakis', 18)}}的其他基金

PRIMER: Promoting Research In MEdical Residency
入门读物:促进住院医师研究
  • 批准号:
    10456018
  • 财政年份:
    2020
  • 资助金额:
    $ 33.62万
  • 项目类别:
Multidisciplinary Training Program in Cardiovascular Epidemiology
心血管流行病学多学科培训项目
  • 批准号:
    10355436
  • 财政年份:
    2016
  • 资助金额:
    $ 33.62万
  • 项目类别:
Multidisciplinary Training Program in Cardiovascular Epidemiology
心血管流行病学多学科培训项目
  • 批准号:
    10615654
  • 财政年份:
    2016
  • 资助金额:
    $ 33.62万
  • 项目类别:

相似海外基金

Using pharmacoepidemiology to optimize antihypertensive medication use to prevent aging-related multimorbidity: Midcareer investigator award in patient-oriented research and mentoring.
利用药物流行病学优化抗高血压药物的使用,以预防与衰老相关的多发病:以患者为导向的研究和指导中的职业中期研究者奖。
  • 批准号:
    10572274
  • 财政年份:
    2023
  • 资助金额:
    $ 33.62万
  • 项目类别:
Midcareer award in aging-related subspecialty research
与衰老相关的专业研究中的职业生涯中期奖
  • 批准号:
    10570687
  • 财政年份:
    2023
  • 资助金额:
    $ 33.62万
  • 项目类别:
Academic Leadership Award for Statistical Training in Multidisciplinary Aging Research
多学科老龄化研究统计培训学术领导奖
  • 批准号:
    10427564
  • 财政年份:
    2022
  • 资助金额:
    $ 33.62万
  • 项目类别:
Mid-Career Mentoring Award in Palliative Care, Aging, and Cognitive Impairment
姑息治疗、老龄化和认知障碍领域的职业生涯中期指导奖
  • 批准号:
    10369952
  • 财政年份:
    2022
  • 资助金额:
    $ 33.62万
  • 项目类别:
Academic Leadership Award for Statistical Training in Multidisciplinary Aging Research
多学科老龄化研究统计培训学术领导奖
  • 批准号:
    10682601
  • 财政年份:
    2022
  • 资助金额:
    $ 33.62万
  • 项目类别:
Mid-Career Mentoring Award in Palliative Care, Aging, and Cognitive Impairment
姑息治疗、老龄化和认知障碍领域的职业生涯中期指导奖
  • 批准号:
    10683932
  • 财政年份:
    2022
  • 资助金额:
    $ 33.62万
  • 项目类别:
Prize 202209PJT - Yves Joannette Award of Excellence in Research in Aging: Can virtual navigation strategies predict polygenic risk of Alzheimer disease and cognitive decline?
奖 202209PJT - Yves Joannette 衰老研究卓越奖:虚拟导航策略能否预测阿尔茨海默病和认知能力下降的多基因风险?
  • 批准号:
    477695
  • 财政年份:
    2022
  • 资助金额:
    $ 33.62万
  • 项目类别:
    Operating Grants
Academic Career Leadership Award in Aging
老龄化学术职业领导奖
  • 批准号:
    10216094
  • 财政年份:
    2021
  • 资助金额:
    $ 33.62万
  • 项目类别:
Academic Career Leadership Award in Aging
老龄化学术职业领导奖
  • 批准号:
    10380889
  • 财政年份:
    2021
  • 资助金额:
    $ 33.62万
  • 项目类别:
Academic Career Leadership Award in Aging
老龄化学术职业领导奖
  • 批准号:
    10615710
  • 财政年份:
    2021
  • 资助金额:
    $ 33.62万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了